The PathOlogist: An automated tool for pathway-centric analysis

BMC Bioinformatics

Volumn 12, Issue , 2011, Pages

  Greenblum, Sharon I ^a,c   Efroni, Sol ^b   Schaefer, Carl F ^c   Buetow, Ken H ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b BAR ILAN UNIVERSITY   (Israel)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER CELLS; GENE EXPRESSION DATA; HIER-ARCHICAL CLUSTERING; MOLECULAR ABUNDANCES; MOLECULAR PATHWAYS; PATHWAY COMPONENTS; PATHWAY INTERACTIONS; STATISTICAL POWER;

ASSOCIATION REACTIONS; CELL CULTURE; GENE EXPRESSION;

TOOLS;

ALGORITHM; ARTICLE; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC DATABASE; GENETICS; GLIOBLASTOMA; HUMAN; METABOLISM; METHODOLOGY; MORTALITY; NEOPLASM; TUMOR CELL LINE;

ALGORITHMS; CELL LINE, TUMOR; CLUSTER ANALYSIS; DATABASES, GENETIC; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GLIOBLASTOMA; HUMANS; METABOLIC NETWORKS AND PATHWAYS; NEOPLASMS;

EID: 79955513489     PISSN: None     EISSN: 14712105     Source Type: Journal    
DOI: 10.1186/1471-2105-12-133     Document Type: Article

References (17)

1. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research 2003, 13(11):2498-504. 10.1101/gr.1239303, 403769, 14597658.
2. Nikitin A, Egorov S, Daraselia N, Mazo I. Pathway studio - the analysis and navigation of molecular networks. Bioinformatics 2003, 19(16):2155-2157. 10.1093/bioinformatics/btg290, 14594725.
3. Van Iersel MP, Kelder T, Pico AR, Hanspers K, Coort S, Conklin BR, Evelo C. Presenting and exploring biological pathways with PathVisio. BMC Bioinformatics 2008, (9):399.
4. Karp P, Paley S, Romero P. The Pathway Tools Software. Bioinformatics 2002, 18:S225-32.
5. Zupan B, Bratko I, Demsar J, Juvan P, Halter JA, Kuspa A, Shaulsky G. GenePath: a system for automated construction of genetic networks from mutant data. Bioinformatics 2003, 19(3):383-389. 10.1093/bioinformatics/btf871, 12584124.
6. Efroni S, Schaefer CF, Buetow KH. Identification of key processes underlying cancer phenotypes using biologic pathway analysis. PLoS ONE 2007, 2:e425. 10.1371/journal.pone.0000425, 1855990, 17487280.
7. Schaefer C, Anthony K, Krupa S, Buchoff J, Day M, Hannay T, Buetow KH. PID: The Pathway Interaction Database. Nucleic Acids Res 2009, (37):D674-9.
8. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, Speed TP. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Research 2003, 31(4):e15. 10.1093/nar/gng015, 150247, 12582260.
9. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A Comparison of Normalization Methods for High Density Oligonucleotide Array Data Based on Bias and Variance. Bioinformatics 2003, 19(2):185-193. 10.1093/bioinformatics/19.2.185, 12538238.
10. Strausberg RL, Buetow KH, Emmert-Buck MR, Klausner RD. The cancer genome anatomy project: building an annotated gene index. Trends Genet 2000, 16:103-106. 10.1016/S0168-9525(99)01937-X, 10689348.
11. Shoemaker RH. The NCI60 Human Tumor Cell line Anticancer Drug Screen. Nature Reviews 2006, 6:813-823.
12. The Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 2008, 455(7216):1061-1068. 10.1038/nature07385, 2671642, 18772890, The Cancer Genome Atlas Research Network.
13. Verhaak RGW, Hoadley KA, Purdom E, Wang V, Qi Y, Wilkerson MD, Miller CR, Ding L, Golub T, Mesirov JP, Alexe G, Lawrence M, O'Kelly M, Tamayo P, Weir BA, Gabriel S, Winckler W, Gupta S, Jakkula L, Feiler HS, Hodgson JG, James CD, Sarkaria JN, Brennan C, Kahn A, Spellman PT, Wilson RK, Speed TP, Gray JW, Meyerson M, Getz G, Perou CM, Hayes DN. Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110. 10.1016/j.ccr.2009.12.020, 2818769, 20129251.
14. Vaske C Benz SC, Sanborn JZ, Earl D, Szeto C, Zhu J, Haussler D, Stuart J. Inference of patient-specific pathway activities from multidimensional cancer genomics data using PARADIGM. Bioinformatics 2010, 26:237-245.
15. Tarca AL, Draghici S, Khatri P, Hassan SS, Mittal P, Kim JS, Kim CJ, Kusanovic JP, Romero R. A Novel Signaling Pathway Impact Analysis (SPIA). Bioinformatics 2008, 25(1):75-82. 10.1093/bioinformatics/btn577, 2732297, 18990722.
16. Hoelzinger DB, Mariani L, Weis J, Woyke T, Berens TJ, McDonough WS, Sloan A, Coons SW, Berens ME. Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. Neoplasia 2005, 7(1):7-16. 10.1593/neo.04535, 1490313, 15720813.
17. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M. Rho/ROCK and MAPK Signaling Pathways Are Involved in Glioblastoma Cell Migration and Proliferation. Anticancer Res 2009, 29:119-12.